STAT+: Pharmalittle: We’re reading about pharma lobbying, an FDA gene-editing pathway, and more

The pharmaceutical industry is increasing its spending to influence Washington, D.C., as it remains one of the most powerful lobbies in the nation. Current topics of interest include pharma lobbying and an FDA gene-editing pathway.